Sclerosis multiplex (SM): vizsgálatok itt: Dánia
19 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study of Orelabrutinib in Patients With Primary Progressive Multiple Sclerosis
- Where
- Esbjerg, Gistrup, Viborg
- Életkor
- 18 év to 60 év
- People
- 705 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07067463 · EU 2025-524316-11-00 - 3. fázisTaking peopleA Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis
- Where
- Gistrup, Viborg
- Életkor
- 18 év to 60 év
- People
- 990 worldwide
- Run by
- Zenas BioPharma (USA), LLC
See details and how to joinNCT07299019 · EU 2025-524322-18-00 - 3. fázisTaking peopleEfficacy and safety study of frexalimab (SAR441344) in adults with relapsing forms of multiple sclerosis
- Where
- Esbjerg, Glostrup
- Életkor
- 18 év to 64 év
- People
- 386 worldwide
- Run by
- Sanofi-Aventis Recherche & Developpement
See details and how to join2023-504358-36-00 · EU 2023-504358-36-00 - 3. fázisTaking peopleEfficacy and Safety of Remibrutinib After Switching From Ocrelizumab in Participants Living With Relapsing Multiple Sclerosis.
- Where
- Aarhus N, Glostrup
- Életkor
- 40 év to 70 év
- People
- 400 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT06846281 · EU 2023-509275-17-00 - 3. fázisTaking peopleA Randomized, Double-blind, Study to Demonstrate Pharmacokinetic Similarity, and Evaluate Safety, Immunogenicity, Pharmacodynamics and Clinical Effects between ABP 692 and Ocrevus® (Ocrelizumab) in Subjects with Relapsing-remitting Multiple Sclerosis
- Where
- Glostrup
- Életkor
- 18 év to 64 év
- People
- 125 worldwide
- Run by
- Amgen Inc.
See details and how to join2024-512914-16-00 · EU 2024-512914-16-00 - No phaseTaking peopleSacral Neuromodulation for Neurogenic Lower Urinary Tract, Bowel and Sexual Dysfunction
- Where
- Odense
- Életkor
- 18 év to 80 év
- People
- 60
- Run by
- Odense University Hospital
See details and how to joinNCT05380856 - 3. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- Where
- Aarhus N, Esbjerg, Glostrup Municipality, Odense C
- Életkor
- 18 év to 65 év
- People
- 1275 worldwide
- Run by
- Novartis Pharmaceuticals
See details and how to joinNCT07225504 - 3. fázisTaking peopleNon-inferiority Study of Frexalimab Subcutaneous Administration Compared to Intravenous Administration in Adult Participants With Multiple Sclerosis
- Where
- Esbjerg, Glostrup
- Életkor
- 18 év to 60 év
- People
- 160 worldwide
- Run by
- Sanofi
See details and how to joinNCT07325292 · EU 2026-525688-41-00 - No phaseTaking peopleAt Home Use of Stimulation Suits for Managing MS Symptoms
- Where
- Ry
- Életkor
- 18 év and over
- People
- 70 worldwide
- Run by
- Daphne Kos
See details and how to joinNCT07202195 - No phaseTaking peopleFatigue Alleviation Through Neuromodulating Therapy in Multiple Sclerosis
- Where
- Hvidovre
- Életkor
- 18 év to 65 év
- People
- 60
- Run by
- Danish Research Centre for Magnetic Resonance
See details and how to joinNCT06569550 - 2. fázisTaking peopleA Phase 2 Study of Obexelimab in Patients with Relapsing Multiple Sclerosis
- Where
- Gistrup
- Életkor
- 18 év to 64 év
- People
- 93 worldwide
- Run by
- Zenas Biopharma (USA) LLC
See details and how to join2024-512707-40-00 · EU 2024-512707-40-00 - 3. fázisTaking peopleA clinical trial to find out how well LOU064 (remibrutinib) works and how safe it is for people with secondary progressive multiple sclerosis
- Where
- Aarhus N, Esbjerg, Glostrup, Odense C
- Életkor
- 18 év and over
- People
- 677 worldwide
- Run by
- Novartis Pharma AG
See details and how to join2025-521546-23-00 · EU 2025-521546-23-00 - 2. fázisTaking peoplePsilocybin Therapy for Psychological Distress in Palliative Patients
- Where
- Copenhagen Nv
- Életkor
- 18 év and over
- People
- 108 worldwide
- Run by
- University Medical Center Groningen
See details and how to joinNCT06782724 · EU 2023-510488-36-01 - No phaseTaking peopleIndole-3-PROpionic Acid Clinical Trials - Multiple Sclerosis
- Where
- Glostrup Municipality
- Életkor
- 18 év to 65 év
- People
- 220
- Run by
- Glostrup University Hospital, Copenhagen
See details and how to joinNCT07318129 - No phaseTaking peopleEXpain Trial - Exercise an a Non-pharmacological Pain-relieving Treatment in People With Multiple Sclerosis
- Where
- Aarhus
- Életkor
- 18 év and over
- People
- 116
- Run by
- University of Aarhus
See details and how to joinNCT07342777 - No phaseTaking peopleEffects of Exercise and Sleep on Motor Learning and Functional Abilities in Multiple Sclerosis
- Where
- Copenhagen, Roskilde
- Életkor
- 18 év to 70 év
- People
- 20
- Run by
- Zealand University Hospital
See details and how to joinNCT07304375 - 2. fázisNot yet taking people in DániaImplementation of an Advanced Telerehabilitation Solution for People With Multiple Sclerosis
- Where
- Haslev, Ry
- Életkor
- 18 év and over
- People
- 94 worldwide
- Run by
- Danish Multiple Sclerosis Hospitals
See details and how to joinNCT07310914 - 2. fázisTaking peopleIlluminating New Paths in the Treatment of Multiple Sclerosis Relapses - Early and Specialized Rehabilitation
- Where
- Haslev, Ry
- Életkor
- 18 év and over
- People
- 64
- Run by
- Lars Hvid
See details and how to joinNCT06956326 - No phaseTaking peopleResistance Training and Corticospinal Excitability in Multiple Sclerosis
- Where
- Aarhus, Copenhagen
- Életkor
- 18 év and over
- People
- 54
- Run by
- University of Aarhus
See details and how to joinNCT06374108